The poster will be made available on the Presentations & Research page of Unicycive’s website following the poster ...

Reverting to pre-COVID telehealth policies could reduce access to care for kidney transplant recipients who live in ...

MediBeacon’s CEO, Steven Hanley, will present at the upcoming Stifel Healthcare Conference in New York on Tuesday, Nov. 11, 2025 at 5:40 AM PST / 8:40 AM EST. Media and Investor Contact Carrie ...

Kidney transplant recipients with active or high risk for antibody-mediated rejection reported transplant benefits but still experienced physical restrictions and psychological concerns, according to ...

Unicycive Therapeutics (UNCY) announced that it will present new oxylanthanum carbonate, OLC, data at the American Society of Nephrology, ASN, ...

The Key Advances in Nephrology collection offers a unique series of specially commissioned ‘Year in Review’ articles that highlight the key discoveries made each year. In these articles, leading ...

Allosite Therapeutics, a biotechnology company discovering and developing innovative integrin therapies for kidney diseases and other immunologic conditions, today announced that the company will ...

In our comprehensive two- to three-year fellowship program, you will receive a broad range of hands-on clinical experience and individualized instruction from nationally known physicians and ...

myCME is the premier destination for continuing medical education (CME) and continuing education (CE), committed to providing high-quality, evidence-based, and user-friendly courses tailored to the ...

The Division of Pediatric Nephrology of the Department of Pediatrics, Baylor College of Medicine, is dedicated to training fellows to become leaders in pediatric nephrology. One of the largest ...